Incidence and Clinical Outcomes of Non-endometrioid Carcinoma of Endometrium: Siriraj Hospital Experience |
Jaishuen, Atthapon
(Department of Obstetrics and Gynaecology, Faculty of Medicine, Siriraj Hospital, Mahidol University)
Kunakornporamat, Kate (Department of Obstetrics and Gynaecology, Faculty of Medicine, Siriraj Hospital, Mahidol University) Viriyapak, Boonlert (Department of Obstetrics and Gynaecology, Faculty of Medicine, Siriraj Hospital, Mahidol University) Benjapibal, Mongkol (Department of Obstetrics and Gynaecology, Faculty of Medicine, Siriraj Hospital, Mahidol University) Chaopotong, Pattama (Department of Obstetrics and Gynaecology, Faculty of Medicine, Siriraj Hospital, Mahidol University) Petsuksiri, Janjira (Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University) Therasakvichya, Suwanit (Department of Obstetrics and Gynaecology, Faculty of Medicine, Siriraj Hospital, Mahidol University) |
1 | Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009). Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet, 373, 125-36. DOI ScienceOn |
2 | Olawaiye AB, Boruta DM (2009). Management of women with clear cell endometrial cancer A Society of Gynecologic Oncology (SGO) review. Gynecologic Oncology, 113, 277-83. DOI ScienceOn |
3 | Siegel R, Naishadham D and Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. DOI ScienceOn |
4 | Slomovitz BM, Burke TW, Eifel PJ, et al (2003). Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol, 91, 463-9. DOI ScienceOn |
5 | Todo Y, Kato H, Kaneuchi M, et al (2010). Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet, 376, 1165-72. |
6 | Wilairat W, Benjapibal M (2012). Presence of anemia and poor prognostic factors in patients with endometrial carcinoma. Asian Pac J Cancer Prev, 13, 3187-90. DOI ScienceOn |
7 | Wilson TO, Podratz KC, Gaffey TA, et al (1990). Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Am J Obstet Gynecol, 162, 418-23. DOI ScienceOn |
8 | Desai NB, Kiess AP, Kollmeier MA, et al (2013). Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy. Gynecol Oncol, 131, 604-8. DOI ScienceOn |
9 | Fader AN, Boruta D, Olawaiye AB, Gehrig PA (2010). Uterine papillary serous carcinoma: epidemiology, pathogenesis and management. Curr Opin Obstet Gynecol, 22, 21-9. DOI |
10 | Ferlay J, Shin HR, Bray F, et al (2008). "GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. |
11 | Hamilton CA, Cheung MK, Osann K, et al (2006). Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer, 94, 642-6. |
12 | Jhingran A, Ramondetta LM, Bodurka DC, et al (2013). A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol, 129, 304-9. DOI ScienceOn |
13 | Kelly MG, O'Malley D M, Hui P, et al (2005). Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol, 98, 353-9. DOI ScienceOn |
14 | Khunhaprema T, Attasara P, Sriplung H, et al (2012). Cancer in Thailand. Volume VI, 2004-2006. Bangkok, National Cancer Institute, Department od Medical Service, Ministry of Public Health. |
15 | Kim HJ, Kim TJ, Lee YY, et al (2013). A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system. J Gynecol Oncol, 24, 120-7. DOI ScienceOn |
16 | Barney BM, Petersen IA, Mariani A, et al (2013). The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer. Int J Radiat Oncol Biol Phys, 85, 109-15. DOI ScienceOn |
17 | Benedetti Panici P, Basile S, Maneschi F, et al (2008). Systematic pelvic lymphadenectomy vs. no lymphadenectomy in earlystage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst, 100, 1707-16. DOI ScienceOn |
18 | Chan JK, Cheung MK, Huh WK, et al (2006). Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer, 107, 1823-30. DOI ScienceOn |
19 | Bjorge T, Engeland A, Tretli S, Weiderpass E (2007). Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer, 120, 378-83. DOI ScienceOn |
20 | Boruta DM, Gehrig PA, Fader AN, Olawaiye AB (2009). Management of women with uterine papillary serous cancer: A Society of Gynecologic Oncology (SGO) review. Gynecologic Oncol, 115, 142-53. DOI ScienceOn |
21 | Chang-Halpenny CN, Natarajan S, Hwang-Graziano J (2013). Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy. Gynecol Oncol, 131, 598-603. DOI ScienceOn |
22 | Creasman WT, Odicino F, Maisonneuve P, et al (2006). Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet, 95, 105-43. DOI ScienceOn |
23 | Gehrig PA, Van Le L, Fowler WC Jr (2003). The role of omentectomy during the surgical staging of uterine serous carcinoma. Int J Gynecol Cancer, 13, 212-5. |